Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST
GH-secreting pituitary tumors
GH4C1 cell line
acromegaly
octreotide
pasireotide
somatostatin receptor ligands
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Apr 2021
10 Apr 2021
Historique:
received:
17
03
2021
accepted:
08
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
First-generation somatostatin receptor ligands (fg-SRLs), such as octreotide (OCT), represent the first-line medical therapy in acromegaly. Fg-SRLs show a preferential binding affinity for somatostatin receptor subtype-2 (SST
Identifiants
pubmed: 33920241
pii: cancers13081816
doi: 10.3390/cancers13081816
pmc: PMC8069349
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Mol Neurobiol. 2017 Sep;54(7):4879-4895
pubmed: 27514754
Ups J Med Sci. 2015;120(3):157-68
pubmed: 25926390
J Clin Endocrinol Metab. 2000 Feb;85(2):781-92
pubmed: 10690891
N Engl J Med. 2020 Mar 5;382(10):937-950
pubmed: 32130815
Endocrinology. 2002 Apr;143(4):1218-24
pubmed: 11897676
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Eur J Endocrinol. 2008 Mar;158(3):295-303
pubmed: 18299461
J Mol Endocrinol. 2014 Jun;52(3):R223-40
pubmed: 24647046
Pharmacol Rev. 2018 Oct;70(4):763-835
pubmed: 30232095
Int J Cancer. 2018 May 1;142(9):1842-1852
pubmed: 29226331
Mol Cell Endocrinol. 2014 Feb 15;382(2):860-70
pubmed: 24211300
Front Cell Neurosci. 2017 Oct 13;11:312
pubmed: 29081734
Exp Cell Res. 2018 Feb 1;363(1):48-64
pubmed: 29305964
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85
pubmed: 15070915
Trends Endocrinol Metab. 2010 Mar;21(3):123-33
pubmed: 20149677
Clin Endocrinol (Oxf). 2003 Jul;59(1):115-28
pubmed: 12807513
Endocrinology. 1968 Feb;82(2):342-52
pubmed: 4951281
Endocr Relat Cancer. 2019 Dec;26(12):853-865
pubmed: 31645017
J Clin Endocrinol Metab. 2019 Mar 1;104(3):915-924
pubmed: 30346538
Endocr Relat Cancer. 2007 Mar;14(1):91-102
pubmed: 17395978
Endocrinology. 2003 Apr;144(4):1574-84
pubmed: 12639942
Mol Endocrinol. 2010 Jan;24(1):240-9
pubmed: 19910453
Mol Pharmacol. 2006 Feb;69(2):539-46
pubmed: 16258074
Mol Endocrinol. 1994 Oct;8(10):1289-97
pubmed: 7854346
Mol Cell Endocrinol. 2008 May 14;286(1-2):192-8
pubmed: 18191325
Acta Neuropathol. 2013 Jul;126(1):123-35
pubmed: 23400299
Endocr Relat Cancer. 2016 Jul;23(7):509-19
pubmed: 27267119
Mol Endocrinol. 2010 Feb;24(2):436-46
pubmed: 20051480
Clin Cancer Res. 2020 Feb 15;26(4):957-969
pubmed: 31624102
Eur J Endocrinol. 2016 Feb;174(2):241-50
pubmed: 26586796
J Endocrinol. 2016 Nov;231(2):135-145
pubmed: 27587848
J Clin Endocrinol Metab. 2021 Mar 8;106(3):789-801
pubmed: 33236108
Nat Rev Endocrinol. 2014 Apr;10(4):243-8
pubmed: 24566817
Mol Endocrinol. 2011 Jun;25(6):1040-54
pubmed: 21493671
J Clin Endocrinol Metab. 2014 Mar;99(3):791-9
pubmed: 24423324
J Clin Endocrinol Metab. 2004 Jun;89(6):3027-32
pubmed: 15181094
Leukemia. 2001 Mar;15(3):342-7
pubmed: 11237055
Eur J Endocrinol. 2002 May;146(5):707-16
pubmed: 11980628
J Clin Endocrinol Metab. 2013 Jan;98(1):E66-71
pubmed: 23118420
Front Neuroendocrinol. 2013 Aug;34(3):228-52
pubmed: 23872332
J Clin Endocrinol Metab. 2001 May;86(5):2161-9
pubmed: 11344221
Endocrinology. 2008 Sep;149(9):4736-46
pubmed: 18566118
Mol Pharmacol. 2009 Jul;76(1):68-80
pubmed: 19389921
Pituitary. 2019 Feb;22(1):89-99
pubmed: 30483918
Front Biosci. 2008 Jan 01;13:822-40
pubmed: 17981589
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5478-5482
pubmed: 31219586
Eur J Endocrinol. 2006 Aug;155(2):371-9
pubmed: 16868153
J Clin Endocrinol Metab. 2009 Nov;94(11):4342-50
pubmed: 19820006
J Clin Endocrinol Metab. 2009 Feb;94(2):654-61
pubmed: 19001514
J Clin Endocrinol Metab. 2017 Jun 1;102(6):2009-2018
pubmed: 28323931
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
J Endocrinol. 2012 Jan;212(1):49-60
pubmed: 21987782
J Clin Endocrinol Metab. 2003 Jun;88(6):2797-802
pubmed: 12788890
J Clin Endocrinol Metab. 2008 Apr;93(4):1203-10
pubmed: 18198230
Cancer Lett. 2018 Oct 28;435:101-109
pubmed: 30098401
Ther Clin Risk Manag. 2020 May 05;16:379-391
pubmed: 32440136
J Clin Endocrinol Metab. 2003 Sep;88(9):4239-45
pubmed: 12970293
Int J Mol Sci. 2019 Aug 13;20(16):
pubmed: 31412614
J Clin Endocrinol Metab. 2004 Oct;89(10):5181-8
pubmed: 15472224
Mol Endocrinol. 2011 May;25(5):859-66
pubmed: 21330405
Mol Cell Endocrinol. 2010 Feb 5;315(1-2):254-62
pubmed: 19932151
PLoS One. 2017 May 18;12(5):e0177934
pubmed: 28542433
J Clin Endocrinol Metab. 2013 Nov;98(11):E1730-9
pubmed: 24092823
J Clin Endocrinol Metab. 2014 May;99(5):1825-33
pubmed: 24606084
Nat Rev Endocrinol. 2020 Oct;16(10):590-607
pubmed: 32839579